Absence of Histologic Retinal Toxicity of Intravitreal Bevacizumab in a Rabbit Model
- 31 July 2006
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 142 (1) , 162-164
- https://doi.org/10.1016/j.ajo.2006.03.058
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumabEye, 2006
- TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)Retina, 2006
- ELECTROPHYSIOLOGIC AND RETINAL PENETRATION STUDIES FOLLOWING INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN)Retina, 2006
- INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY VITREOUS HEMORRHAGERetina, 2006
- INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR REFRACTORY PSEUDOPHAKIC CYSTOID MACULAR EDEMARetina, 2006
- Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein OcclusionOphthalmic Surgery, Lasers and Imaging Retina, 2005